Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Wu

Showing results (341-350 of 343) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 343 results.
JAMA Dermatology|September 25, 2024
Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical TrialDaying Zhang, Tiechi Lei, Lanying Qin, et al.
Science Immunology|August 8, 2017
Potent and broad HIV-neutralizing antibodies in memory B cells and plasmaLaTonya D Williams, Gilad Ofek, Sebastian Schätzle, et al.
Frontiers in Immunology|June 25, 2026
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 studyLin Cai, Jing Chen, Liming Wu, et al.
Pageof 35

Showing results (341-350 of 343) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 343 results.
JAMA Dermatology|September 25, 2024
Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical TrialDaying Zhang, Tiechi Lei, Lanying Qin, et al.
Science Immunology|August 8, 2017
Potent and broad HIV-neutralizing antibodies in memory B cells and plasmaLaTonya D Williams, Gilad Ofek, Sebastian Schätzle, et al.
Frontiers in Immunology|June 25, 2026
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 studyLin Cai, Jing Chen, Liming Wu, et al.
Pageof 35